<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>High expression of disabled homolog 2-interacting protein contributes to tumor development and proliferation in cutaneous squamous cell carcinoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="High expression of disabled homolog 2-interacting protein contributes to tumor development and proliferation in cutaneous squamous cell carcinoma." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40a2/7576015/e3161f3703b2/atm-08-18-1131-f9.jpg"/> </div> <div class="text-side"> <h1>High expression of disabled homolog 2-interacting protein contributes to tumor development and proliferation in cutaneous squamous cell carcinoma.</h1> <p>DAB2IP knockdown inhibited SCL-1 cell invasiveness. (A) Giemsa staining. Magnification, ×100. Invasion assays were performed in wild-type cells and in cells with stable knockdown of DAB2IP. Representative photographs are presented, and the relative number of invading cells was counted. (B) The data were quantified and presented as the mean ± SEM of three independent experiments. Statistical significance was determined by one-way ANOVA. DAB2IP, disabled homolog 2-interacting protein; CON, control; NC, negative control group; KD, knockdown of DAB2IP. ***, P&lt;0.001.</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33240980/" target="_blank">33240980</a></p><p>Type: Premalignant/Malignant, Category: Keratinocytic</p>
</div> </div></div></body></html>